Shinepro Life Sciences Private Limited

Supplies pharmaceutical products and offers PCD, franchise, and manufacturing services.

2021 | Panchkula, Haryana (India) | Active
Last Updated: December 08, 2024

Shinepro Life Sciences Profile

Key Indicators

  • Authorised Capital ₹ 7.00 M
  • Paid Up Capital ₹ 4.36 M
  • Company Age 3 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.38 Cr
  • Revenue Growth 23.20%
  • Profit Growth 24.45%
  • Ebitda 170.37%
  • Net Worth 14.17%
  • Total Assets 198.46%

About Shinepro Life Sciences

Shinepro Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 February 2021 (Three years and 11 months 23 days old ). Its registered office is in Panchkula, Haryana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 4.36 M.

The company currently has active open charges totaling ₹3.38 Cr.

Mithoon Bhatia, Shilpa Chandel, Aakriti Raina, and Two other members serve as directors at the Company.

Company Details

  • Location

    Panchkula, Haryana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230HR2021PTC092948

  • Company No.

    092948

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Feb 2021

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Shinepro Life Sciences Private Limited offer?

Shinepro Life Sciences Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Sexual Wellness Products, Fertility Enhancer, Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Dietary Supplements, Mineral Supplement, Medicinal Plant.

Who are the key members and board of directors at Shinepro Life Sciences?

Board Members (5)

Name Designation Appointment Date Status
Shilpa Chandel Country flag representing In Director 16-Sep-2021 Current
Mithoon Bhatia Country flag representing In Director 16-Feb-2021 Current
Aakriti Raina Country flag representing In Director 04-Dec-2021 Current
Gitanjli Country flag representing In Director 04-Dec-2021 Current
Priyanka Country flag representing In Director 19-Oct-2023 Current

Financial Performance of Shinepro Life Sciences.

Shinepro Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.2% increase. The company also saw a substantial improvement in profitability, with a 24.45% increase in profit. The company's net worth Soared by an impressive increase of 14.17%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
23.20%
Revenue from Operations
23.20%
Total Assets
198.46%
Profit or Loss
24.45%
Net Worth
14.17%
EBITDA
170.37%

What is the Ownership and Shareholding Structure of Shinepro Life Sciences?

In 2023, Shinepro Life Sciences had a promoter holding of 23.80% and a public holding of 76.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹33.80 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Canara Bank : 3.38 Cr

Latest Charge Details

Date Lender Amount Status
09 Jun 2022 Canara Bank ₹2.58 Cr Open
30 Oct 2021 Canara Bank ₹8.00 M Open

How Many Employees Work at Shinepro Life Sciences?

Shinepro Life Sciences has a workforce of 10 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shinepro Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shinepro Life Sciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Shinepro Life Sciences

Recent activity within the organization

  • Annual General Meeting

    Shinepro Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Shinepro Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Charges

    A charge with Canara Bank of Rs. 8.00 M registered on 30 Oct 2021 with Charge ID 100505798 was modified on 20 Feb 2024.

    20 Feb 2024

  • Director Appointment

    Priyanka was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 1 year 3 months .

    19 Oct 2023

  • Charges

    A charge with Canara Bank of Rs. 25.80 M registered on 09 Jun 2022 with Charge ID 100586837 was modified on 27 Oct 2022.

    27 Oct 2022

  • Charges

    A charge with Canara Bank amounted to Rs. 25.80 M with Charge ID 100586837 was registered on 09 Jun 2022.

    09 Jun 2022

Frequently asked questions

  • Shinepro Life Sciences Private Limited was incorporated on 16 Feb 2021.

  • The authorized share capital of Shinepro Life Sciences Private Limited is ₹ 7.00 M and paid-up capital is ₹ 4.36 M.

  • Currently 5 directors are associated with Shinepro Life Sciences Private Limited.

    • Mithoon Bhatia
    • Shilpa Chandel
    • Aakriti Raina
    • Gitanjli
    • Priyanka
  • As per Ministry of Corporate Affairs (Mca), the registered address of Shinepro Life Sciences Private Limited is Plot 331 2Nd Floor Ind Area Phase -1 India, Panchkula, Haryana, 134113.

  • The corporate identification number (CIN) of Shinepro Life Sciences Private Limited is U24230HR2021PTC092948 and the company number is 092948 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Shinepro Life Sciences Private Limited has risen by 23.20%.

  • As Per 2023 financial reports, 10 employees are currently employed by Shinepro Life Sciences Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Shinepro Life Sciences Private Limited has experienced an upsurge of 14.17%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Shinepro Life Sciences Private Limited amount to ₹ 3.38 Cr.

  • The most recent Balance Sheet for Shinepro Life Sciences Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors